Bleeding Peptic Ulcer
9
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
The Use of OTSC in LBGDU to Standard Endoscopic Hemostatic Methods
Over-the-scope Clip Versus Through-the-scope Clip for Endoscopic Hemostasis of High Risk Bleeding Peptic Ulcers
Argon Plasma Coagulation vs Hemoclipping for Bleeding Peptic Ulcers
Oral Omeprazole in Bleeding Peptic Ulcer
Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB)
High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers
Prevention of Gastric Ulcer Bleeding by Using "Computer-alert" in General Practice
Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy